Cancer News and Research

Latest Cancer News and Research

Partial, whole breast radiation after lumpectomy yield similar cosmetic outcomes

Whole breast radiation and partial breast radiation following a lumpectomy yield similar cosmetic outcomes for women diagnosed with early stages of cancer who wish to preserve their breasts.

26 Sep 2019

Arthritis drug could be used to treat lichen planus skin rash

Constant itchy, painful bumps, scaly arms and legs, and damaged nails make lichen planus an inflammatory skin disease that's both frustrating and painful for patients trying to keep their quality of life.

26 Sep 2019

AI accurately predicts radiation therapy side effects for patients with head and neck cancers

For the first time, a sophisticated computer model has been shown to accurately predict two of the most challenging side effects associated with radiation therapy for head and neck cancer.

26 Sep 2019

High-dose radiation effective for men whose prostate cancer has spread, trial shows

A randomized clinical trial of targeted, high-dose radiation for men with oligometastatic prostate cancer has shown the treatment to be an effective and safe option for patients who wish to delay hormone-suppression therapy.

26 Sep 2019

Researcher aims to make CRISPR-Cas9 system safer and more precise

The mere mention of gene editing and DNA altering might conjure up images of designer babies, but that is not what researcher Jin Liu has in mind.

26 Sep 2019

Adding radiation after immunotherapy increases PFS for some patients with metastatic NSCLC

Adding precisely aimed, escalated doses of radiation after patients no longer respond to immunotherapy reinvigorates the immune system in some patients with metastatic non-small-cell lung cancer, increasing progression-free survival.

26 Sep 2019

Noninvasive radiation therapy offers new hope for patients with high-risk heart arrhythmias

Treating high-risk heart patients with a single, high dose of radiation therapy can dramatically reduce episodes of rapid, abnormal heartbeats for more than two years, offering hope to patients who have exhausted other treatment options.

26 Sep 2019

New discovery sheds light on how pancreatic cancer fuels its growth

A new discovery about pancreatic cancer sheds light on how the cancer fuels its growth and may help explain how promising cancer drugs work - and for whom they will fail.

26 Sep 2019

Long-term hormone therapy does more harm than good for men with low PSAs after prostate surgery

A secondary analysis of a recent clinical trial that changed the standard of care for men with recurring prostate cancer finds long-term hormone therapy does more harm than good for many men and calls for rethinking treatment guidelines based on a patient's post-operative prostate-specific antigen (PSA) level.

26 Sep 2019

Study shows miRNAs in semen as non-invasive biomarkers for prostate cancer

Researchers of the Human Molecular Genetics group at the Bellvitge Biomedical Research Institute, led by Dr. Sara Larriba, in collaboration with Dr. Francesc Vigués and Dr. Manel Castells of the Urology Service of Bellvitge University Hospital, show the usefulness of certain molecules, the miRNAs in semen, as non-invasive biomarkers for prostate cancer.

26 Sep 2019

New NIH program aims to improve lives for people with inherited blood and immune diseases

People with inherited diseases of the blood and immune system can now receive treatment at the National Institutes of Health Clinical Center through a new, streamlined program that integrates expertise from many medical specialties and related basic science disciplines.

26 Sep 2019

Closure of women's health clinics linked to lower cervical cancer screening and higher mortality

Following the closure of nearly 100 women's health clinics across the United States from 2010 to 2013, fewer women were screened for cervical cancer, more women were diagnosed with advanced stages of the disease and mortality rates rose.

26 Sep 2019

Tasmanian devil study may give clues to how cancers evade the immune system

A cluster of interacting proteins that are active in both human cancers and Tasmanian devil facial tumors, may give clues to how cancers evade the immune system, according to a study part-funded by Cancer Research UK and published in Cancer Cell today.

26 Sep 2019

Metabolite may predict cancer versus autism risk in PTEN patients

In a new study published in American Journal of Human Genetics, a team of researchers led by Charis Eng, M.D., Ph.D., Chair of Cleveland Clinic's Genomic Medicine Institute, identified a metabolite that may predict whether individuals with PTEN mutations will develop cancer or autism spectrum disorder.

26 Sep 2019

Minimum unit pricing of alcohol leads to consumption decline in Scotland

Since Scotland has introduced minimum unit pricing (MUP), a study has found that there has been a decrease in alcohol consumption.

26 Sep 2019

Prostate cancer risk linked to assisted reproduction techniques

A study published in BMJ has revealed a link between the risk of prostate cancer and men who have become fathers via assisted reproduction techniques.

26 Sep 2019

Personal Genome Diagnostics applies CE mark to PGDx elio tissue complete assay

Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, today announced that it has applied the CE mark to the PGDx elio™ tissue complete assay.

26 Sep 2019

An effective strategy to deter tobacco use in middle and high school students

An innovative strategy called Teens Against Tobacco Use showed promise as an effective strategy to deter tobacco use in middle and high school students, according to a research study by The University of Texas Health Science Center at Houston (UTHealth) School of Public Health.

26 Sep 2019

Study explores link between assisted reproduction and prostate cancer risk

In a new national register study from Lund University in Sweden, researchers have studied the link between prostate cancer and infertility. The study, published in the British Medical Journal, includes over one million Swedish men.

26 Sep 2019

Investigational drug may offer new treatment option for patients with lung and kidney cancer

Pegilodecakin, a first-in-class drug currently in clinical trials, has shown positive safety results and may offer a potential new treatment avenue for patients with non-small cell lung cancer (NSCLC) and kidney cancer.

26 Sep 2019

Cancer News and Research

Latest Cancer News and Research

Partial, whole breast radiation after lumpectomy yield similar cosmetic outcomes

Arthritis drug could be used to treat lichen planus skin rash

AI accurately predicts radiation therapy side effects for patients with head and neck cancers

High-dose radiation effective for men whose prostate cancer has spread, trial shows

Researcher aims to make CRISPR-Cas9 system safer and more precise

Adding radiation after immunotherapy increases PFS for some patients with metastatic NSCLC

Noninvasive radiation therapy offers new hope for patients with high-risk heart arrhythmias

New discovery sheds light on how pancreatic cancer fuels its growth

Long-term hormone therapy does more harm than good for men with low PSAs after prostate surgery

Study shows miRNAs in semen as non-invasive biomarkers for prostate cancer

New NIH program aims to improve lives for people with inherited blood and immune diseases

Closure of women's health clinics linked to lower cervical cancer screening and higher mortality

Tasmanian devil study may give clues to how cancers evade the immune system

Metabolite may predict cancer versus autism risk in PTEN patients

Minimum unit pricing of alcohol leads to consumption decline in Scotland

Prostate cancer risk linked to assisted reproduction techniques

Personal Genome Diagnostics applies CE mark to PGDx elio tissue complete assay

An effective strategy to deter tobacco use in middle and high school students

Study explores link between assisted reproduction and prostate cancer risk

Investigational drug may offer new treatment option for patients with lung and kidney cancer

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Newsletters you may be interested in